IOL CHEMICALS & PHARM. | JUBILANT PHARMOVA | IOL CHEMICALS & PHARM./ JUBILANT PHARMOVA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | -3,188.9 | - | View Chart |
P/BV | x | 1.5 | 2.0 | 76.2% | View Chart |
Dividend Yield | % | 1.0 | 0.7 | 138.4% |
IOL CHEMICALS & PHARM. JUBILANT PHARMOVA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
JUBILANT PHARMOVA Mar-23 |
IOL CHEMICALS & PHARM./ JUBILANT PHARMOVA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 496 | 108.3% | |
Low | Rs | 272 | 269 | 101.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 394.4 | 95.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | -4.1 | -581.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 30.7 | 102.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 5.00 | 80.0% | |
Avg Dividend yield | % | 1.0 | 1.3 | 75.6% | |
Book value per share (Unadj.) | Rs | 256.8 | 338.6 | 75.8% | |
Shares outstanding (eoy) | m | 58.71 | 159.28 | 36.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.0 | 110.5% | |
Avg P/E ratio | x | 17.1 | -93.8 | -18.2% | |
P/CF ratio (eoy) | x | 12.8 | 12.4 | 103.0% | |
Price / Book Value ratio | x | 1.6 | 1.1 | 139.5% | |
Dividend payout | % | 16.9 | -122.7 | -13.7% | |
Avg Mkt Cap | Rs m | 23,743 | 60,873 | 39.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 21,660 | 7.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 62,817 | 35.3% | |
Other income | Rs m | 256 | 383 | 66.8% | |
Total revenues | Rs m | 22,427 | 63,201 | 35.5% | |
Gross profit | Rs m | 2,257 | 7,317 | 30.8% | |
Depreciation | Rs m | 462 | 5,540 | 8.3% | |
Interest | Rs m | 165 | 1,882 | 8.8% | |
Profit before tax | Rs m | 1,887 | 278 | 679.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 927 | 53.4% | |
Profit after tax | Rs m | 1,391 | -649 | -214.5% | |
Gross profit margin | % | 10.2 | 11.6 | 87.4% | |
Effective tax rate | % | 26.2 | 333.5 | 7.9% | |
Net profit margin | % | 6.3 | -1.0 | -607.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 37,624 | 25.7% | |
Current liabilities | Rs m | 5,025 | 17,724 | 28.4% | |
Net working cap to sales | % | 20.9 | 31.7 | 66.1% | |
Current ratio | x | 1.9 | 2.1 | 90.6% | |
Inventory Days | Days | 43 | 25 | 176.5% | |
Debtors Days | Days | 8 | 56 | 14.9% | |
Net fixed assets | Rs m | 11,017 | 71,668 | 15.4% | |
Share capital | Rs m | 587 | 159 | 369.0% | |
"Free" reserves | Rs m | 14,490 | 53,772 | 26.9% | |
Net worth | Rs m | 15,077 | 53,931 | 28.0% | |
Long term debt | Rs m | 0 | 31,104 | 0.0% | |
Total assets | Rs m | 20,684 | 109,292 | 18.9% | |
Interest coverage | x | 12.5 | 1.1 | 1,085.2% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 186.5% | |
Return on assets | % | 7.5 | 1.1 | 666.8% | |
Return on equity | % | 9.2 | -1.2 | -767.1% | |
Return on capital | % | 13.6 | 2.5 | 535.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 4.1 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 2,564 | 0.0% | |
Fx inflow | Rs m | 5,930 | 7,100 | 83.5% | |
Fx outflow | Rs m | 6,052 | 2,564 | 236.0% | |
Net fx | Rs m | -122 | 4,536 | -2.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 6,607 | 18.5% | |
From Investments | Rs m | -1,200 | -5,444 | 22.0% | |
From Financial Activity | Rs m | -41 | -1,567 | 2.6% | |
Net Cashflow | Rs m | -18 | 301 | -6.1% |
Indian Promoters | % | 48.2 | 47.4 | 101.7% | |
Foreign collaborators | % | 0.0 | 3.3 | - | |
Indian inst/Mut Fund | % | 1.7 | 22.8 | 7.4% | |
FIIs | % | 1.4 | 19.1 | 7.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.3 | 105.0% | |
Shareholders | 130,003 | 92,264 | 140.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Jubilant Pharmova | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | 0.51% | -0.57% |
1-Month | 4.77% | 20.78% | 0.07% |
1-Year | -0.25% | 124.42% | 52.18% |
3-Year CAGR | -13.23% | -4.68% | 14.04% |
5-Year CAGR | 16.12% | -0.04% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Jubilant Pharmova share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Jubilant Pharmova.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Jubilant Pharmova.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.